Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion. Shares of the company opened ...

As power demand surges, LNG has a critical role to play in providing a reliable, flexible fuel source that can be quickly ...

The company launched the IPO after doubling revenue in 2024, driven by increased oil production from well acquisitions worth ...

Infinity is going public after more than doubling its revenue in the first nine months of 2024. The strong growth came as the ...